Search

Your search keyword '"Lissy de Ridder"' showing total 61 results

Search Constraints

Start Over You searched for: Author "Lissy de Ridder" Remove constraint Author: "Lissy de Ridder" Language undetermined Remove constraint Language: undetermined
61 results on '"Lissy de Ridder"'

Search Results

1. Dual Biologic or Small Molecule Therapy in Refractory Pediatric Inflammatory Bowel Disease (DOUBLE-PIBD): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN

3. Rotterdam Transition Test: A Valid Tool for Monitoring Disease Knowledge in Adolescents With Inflammatory Bowel Disease

4. Safety of Thioguanine in Pediatric Inflammatory Bowel Disease: A Multi-Center Case Series

5. Venous Thromboembolic Complications in Pediatric Gastrointestinal Diseases: Inflammatory Bowel Disease and Intestinal Failure

6. Health Care Transition Outcomes in Inflammatory Bowel Disease: A Multinational Delphi Study

7. Cannabis, a potential treatment option in pediatric IBD? Still a long way to go

8. Use of Biosimilars in Pediatric Inflammatory Bowel Disease: An Updated Position Statement of the Pediatric IBD Porto Group of ESPGHAN

9. High Impact of Pediatric Inflammatory Bowel Disease on Caregivers’ Work Productivity and Daily Activities: An International Prospective Study

10. Sa1438: TIME TO CHOLANGIOCARCINOMA IN PEDIATRIC ONSET PSC-IBD

11. Reply to 'Re: Diagnosis, Management, and Prevention of Button Battery Ingestion in Childhood: An ESPGHAN Position Paper'

13. Infliximab Level Between Venous and Capillary Blood Using Novel Device Strongly Correlate in Paediatric Inflammatory Bowel Disease Patients

14. Outcomes Following Pouch Formation in Paediatric Ulcerative Colitis: A Study From the Porto Group of ESPGHAN

15. Predicting Outcomes in Pediatric Ulcerative Colitis for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program

16. Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program

17. Malignancy and Mortality in Pediatric-onset Inflammatory Bowel Disease: A Systematic Review

18. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition

20. 730 INCREASED RISK OF VENOUS THROMBOEMBOLISM IN PAEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE - A STUDY OF THE INTERNATIONAL PROSPECTIVE SAFETY REGISTRY

21. Development and Function of Immune Cells in an Adolescent Patient With a Deficiency in the Interleukin-10 Receptor

22. The use of biosimilars in paediatric inflammatory bowel disease

23. Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN

24. Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment (Preprint)

25. Frequencies of circulating regulatory TIGIT(+)CD38(+) effector T cells correlate with the course of inflammatory bowel disease

27. Identifying Health Economic Considerations to Include in the Research Protocol of a Randomized Controlled Trial (the REDUCE-RISK Trial): Systematic Literature Review and Assessment

28. Paediatric multiple magnet ingestion

29. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn’s disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course

30. Mo1988 THE PEDIATRIC ENDOSCOPY PRACTICE IN EUROPE: PRELIMINARY RESULTS OF A WEB-BASED SURVEY ON BEHALF OF THE ENDOSCOPY SPECIAL INTEREST GROUP OF EUROPEAN SOCIETY OF GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION (ESPGHAN)

31. 947 TOP-DOWN INFLIXIMAB SUPERIOR TO STEP-UP IN CHILDREN WITH MODERATE-TO-SEVERE CROHN'S DISEASE - A MULTICENTER RANDOMIZED TRIAL

33. 1163 STEP-CD STUDY: USTEKINUMAB USE IN PAEDIATRIC CROHN'S DISEASE. A MULTICENTRE RETROSPECTIVE STUDY

34. Development and Validation of the Mucosal Inflammation Noninvasive Index For Pediatric Crohn’s Disease

35. OP38 Top-down infliximab superior to step-up in children with Moderate-to-Severe Crohn’s disease: A multicentre randomised controlled trial

36. Corrigendum: Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN

37. Frequencies of circulating regulatory TIGIT

38. The Continental Divide: Anti-TNF Use in Pediatric IBD Is Different in North America Compared to Other Parts of the World

39. Nutrition in Pediatric Inflammatory Bowel Disease: A Position Paper on Behalf of the Porto Inflammatory Bowel Disease Group of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition

41. Use of Biosimilars in Paediatric Inflammatory Bowel Disease

42. Methotrexate for Maintaining Remission in Paediatric Crohn's Patients with Prior Failure or Intolerance to Thiopurines: A Multicenter Cohort Study

43. Benefits and Risks of Combining Anti-tumor Necrosis Factor with Immunomodulator Therapy in Pediatric Inflammatory Bowel Disease

44. Correction to: Eosinophilic myenteric ganglionitis as a cause of chronic intestinal pseudo-obstruction

45. Congenital proprotein convertase 1/3 deficiency causes malabsorptive diarrhea and other endocronopathies in a pediatric cohort

46. Antitumor necrosis factor treatment for pediatric inflammatory bowel disease

47. Risk of infection and preventon in pediatric patients with IBD: ESPGHAN IBD Porto Group Commentary

48. Single-balloon enteroscopy, magnetic resonance enterography, and abdominal US useful for evaluation of small-bowel disease in children with (suspected) Crohn's disease

49. New Kids in the Neighborhood: Biosimilars

50. Percutaneous endoscopic gastrostomy (PEG) in children is not a minor procedure: risk factors for major complications

Catalog

Books, media, physical & digital resources